Exclusive Private Group

Affiliates & Producers Only

$299 value$29.90/mo90% off
Last 2 Spots
Back to Home
4 views
Be the first to rate

Guruko Furudamu Review and Ads Breakdown

Guruko Furudamu is promoted through a dramatic diabetes-focused video sales letter built around fear, personal tragedy, Japanese longevity, and a claimed hidden cause of uncontrolled blood sugar. T…

Daily Intel TeamJune 16, 2026Updated 24 min

8,226+

Videos & Ads

+50-100

Fresh Daily

$29.90

Per Month

Full Access

12.5 TB database · 72+ niches · 24 min read

Join

Guruko Furudamu is promoted through a dramatic diabetes-focused video sales letter built around fear, personal tragedy, Japanese longevity, and a claimed hidden cause of uncontrolled blood sugar. The central premise is not subtle: according to the presentation, diabetes is not mainly about sugar, carbohydrates, sleep, stress, or even genetics. Instead, the VSL claims a so-called 'diabetes parasite' attacks the pancreas, disrupts beta cells, makes the body resistant to insulin, and drives years of elevated glucose.

That is the core of this Guruko Furudamu review: not whether the marketing is emotionally powerful, because it clearly is, but what the transcript actually says, what it does not say, and how the offer is structured to persuade someone who is tired, scared, medicated, and still seeing poor glucose numbers.

The transcript presents a narrator named Yumi Takahashi, described as a 53-year-old doctor specializing in nutrition and health, a 1996 Johns Hopkins University graduate, and a physician with 28 years of experience. Her story begins with a warning about diabetes medications such as Ozempic, Metformin, and insulin, then shifts into a personal account involving her daughter, her husband John, and a return to Japan to investigate why older residents in places such as Nagano, Okinawa, and other Japanese island regions allegedly have very low diabetes rates despite eating sweets and carbohydrates.

This review is grounded only in the provided VSL and ad transcript. That matters because the transcript makes large claims, but it does not provide a full supplement facts label, a named clinical study, a price, a guarantee, or complete buyer testimonials. So the honest version of the review has to separate what the manufacturer claims from what the transcript actually proves.

What Is Guruko Furudamu

Guruko Furudamu appears to be a diabetes or blood sugar support offer promoted through a long-form VSL. The product name is supplied in the task, but the transcript itself focuses more on the story and mechanism than on the bottle, label, serving size, delivery format, or formula.

The product is positioned in the diabetes niche, specifically around people with type 2 diabetes, prediabetes, or long-term blood sugar problems. The VSL speaks directly to viewers who are already using or considering diabetes medications and who feel that their glucose readings are still unpredictable. It also speaks to family members of diabetics, opening with: 'If you or someone in your family is diabetic, listen carefully.'

The format is best described as a video sales letter offer, not a clearly documented clinical product presentation. The transcript does not disclose whether Guruko Furudamu is a capsule, powder, liquid, tea, tincture, recipe, or digital protocol. The ad says a 'simple herbal mixture' can allegedly flush out the parasite, but the VSL excerpt provided does not identify the herbs.

That lack of disclosure is important. In supplement reviews, ingredients are usually the place where claims can be evaluated. For Guruko Furudamu ingredients, the provided transcript gives no confirmed list. It offers a mechanism story and a dramatic promise, but not the formula details a careful buyer would need before making a health decision.

The VSL frames the product as an alternative to relying only on medications. However, readers should be careful here: diabetes medications should never be stopped, replaced, or reduced based on a marketing video. The presentation repeatedly criticizes medications such as Metformin, Ozempic, and insulin, but those are real medical therapies used under professional supervision. The transcript's claims should be treated as marketing claims, not medical instructions.

The Problem It Targets

The main pain point in the Guruko Furudamu VSL is uncontrolled blood sugar despite doing what patients are usually told to do. The presentation describes people who monitor glucose, follow strict diets, exercise regularly, take medications, and still wake up with elevated fasting glucose or see large spikes after meals.

The narrator's daughter is used as the most intense example. According to the presentation, she followed standard diabetes management: constant glucose monitoring, strict diet, regular exercise, and daily use of Ozempic, Metformin, and insulin. Despite that, her fasting readings allegedly reached over 142, and two hours after meals they allegedly spiked beyond 325. The story then says she died from sudden cardiac arrest on June 4, 2021, after diabetes complications.

The second major example is the narrator's husband, John, presented as a 59-year-old man with type 2 diabetes. After their daughter's death, the transcript says John's health declined, his blood sugar climbed, medications no longer seemed effective, and he developed diabetic neuropathy. The story escalates with a foot wound that allegedly became an ulcer, creating fear of possible amputation.

Beyond glucose numbers, the presentation agitates several emotional and physical frustrations: fatigue, fear of complications, anxiety around glucose devices, guilt around desserts, expensive treatments, loss of vitality, and dependency on medications. It also claims diabetes medications are linked to erectile dysfunction in men and loss of libido in women, framing standard treatment as something that steals passion and energy.

The transcript's problem framing is aggressive. It tells viewers their body is becoming 'a fragile shell' and a 'puppet whose strings are pulled by Big Pharma.' It also claims medications are becoming less effective over time, comparing glucose control to 'a runaway car on a winding road.'

For direct-response marketing, this is classic problem agitation. The viewer is not merely told, 'Your blood sugar is high.' They are told they may be trapped in a system that profits from keeping them dependent, that their medications may be dangerous, and that the real cause has been hidden from them.

How Guruko Furudamu Works

According to the presentation, Guruko Furudamu is tied to a root-cause theory built around the alleged 'diabetes parasite.' The VSL says this parasite lodges in the pancreas, gradually destroys cells responsible for insulin production, and compromises the organ over time.

The presentation further claims that this alleged parasite makes the body resistant to insulin and interferes with beta cells, which are essential for pancreatic function. The ad version sharpens this into a more visual hook, asking whether there is really a 2.5 centimeter parasite living in the pancreas and whether it is really the cause of type 2 diabetes.

The ad answers its own question with 'Yes', then claims less than 1% of people know this alleged root cause. It lists symptoms such as tingling in the hands and feet, fatigue, excessive thirst, and frequent trips to the bathroom, presenting them as symptoms caused by the parasite.

The mechanism is framed as simple: the parasite is allegedly weak, and a simple herbal mixture can flush it out of the body. The ad claims that 'in just a few hours' the viewer can expel the parasite through urine, eliminate excess sugar, and see symptoms disappear within days. Those are claims from the ad transcript, not proven outcomes established by the provided material.

The VSL also claims that food is not the true reason glucose remains high. It argues that sweets, soda, fast food, stress, lack of sleep, and emotional factors may cause temporary spikes, but they do not explain constant high blood sugar for years. The narrator asks why glucose is high upon waking if the person has not eaten sugar during sleep. This is used to move the viewer away from conventional explanations and toward the parasite mechanism.

From a marketing perspective, this is the unique mechanism. Many blood sugar supplements talk about insulin sensitivity, carbohydrate metabolism, chromium, cinnamon, or glucose uptake. Guruko Furudamu is positioned differently: it claims there is a hidden biological enemy in the pancreas, and that the solution is to eliminate that enemy.

However, the transcript does not provide medical evidence that such a parasite causes 96% of diabetes cases. It mentions 'recent studies', but does not name them. There are no authors, journal titles, publication dates, trial designs, images, lab methods, or citations in the provided text. A serious reader should treat the parasite mechanism as a marketing claim until independently verified by qualified medical evidence.

Key Ingredients and Components

The biggest factual gap in this Guruko Furudamu ingredients review is simple: the transcript does not disclose the ingredient list.

The ad says there is a 'simple herbal mixture'. The VSL says the narrator will reveal a method and a simple step-by-step plan. But the provided text does not name a single confirmed ingredient, botanical, mineral, enzyme, probiotic, antiparasitic compound, or dosage.

That means we cannot honestly say that Guruko Furudamu contains berberine, cinnamon, chromium, bitter melon, alpha-lipoic acid, gymnema, banaba, fenugreek, vanadium, or any other common blood sugar support nutrient. Those ingredients are typical in the category, but they are not confirmed by the transcript.

This distinction matters. A typical blood sugar supplement might use ingredients positioned around glucose metabolism, insulin sensitivity, carbohydrate processing, or oxidative stress support. A typical herbal cleanse might use botanicals positioned around digestion or elimination. But Guruko Furudamu, as presented in the transcript, is not described through a conventional supplement facts panel. It is described through a story: Japan, longevity, a grieving doctor, a sick husband, and a hidden pancreatic parasite.

The VSL's most concrete components are narrative components rather than formula components. These include Japanese island populations, Nagano longevity, a glucose reading of 108 after sweets, the narrator's medical identity, the family tragedy, the claimed 5,500 families helped, and the alleged parasite mechanism.

For a buyer, this is a practical concern. Before considering any supplement in the diabetes niche, the basics matter: ingredients, dosages, contraindications, drug interactions, manufacturing standards, third-party testing, and who should not use it. None of those are disclosed in the supplied transcript.

Because diabetes is a high-stakes health condition, the absence of an ingredient list is not a minor omission. People using Metformin, insulin, GLP-1 medications, blood pressure drugs, anticoagulants, or kidney-related treatments need professional guidance before adding herbs or supplements. Some natural ingredients can affect glucose levels or interact with medications.

The VSL Hook and Story

The Guruko Furudamu VSL begins with alarm. It tells diabetics and their family members that common diabetes medications are 'loaded with substances' that allegedly turn cells into 'ticking time bombs' and may lead to cancer. It claims leading nations are on high alert, that the risk has spread to over 97 countries, and that the situation worsened this month.

The villain is established quickly: Big pharmaceutical companies. The VSL claims these companies pull strings behind the scenes, influence politicians, hide information from major media outlets, and keep people dependent on dangerous medications. The presentation also references the pandemic as a reason viewers should not doubt the power of pharmaceutical companies.

After the fear-based opening, the VSL shifts into hope. It says medications are not the only option and claims viewers can learn the real cause of high blood sugar. The narrator insists, 'You weren't born diabetic,' then introduces the idea that glucose can return to normal if the true cause is addressed.

The story then moves to Japan. The narrator claims that islands or regions such as Nakagawa, Okinawa, and Nagano have some of the lowest diabetes rates in the world, around 0.5% of the population. The transcript says these people eat foods that would be considered unhealthy elsewhere, yet live nearly 90 or 95 years without diabetes.

The most vivid scene is the meal with the narrator's grandfather in Nagano. He is described as 92 years old, surrounded by older friends eating donuts, cupcakes, cheesecake, french fries, and cornbread. The narrator, as a diabetes specialist, panics. Then she tests his glucose and sees 108, which she presents as shocking because he had just eaten sugar and carbohydrates.

This scene is the VSL's anomaly. It asks: if older Japanese residents can eat sweets and remain metabolically healthy, then perhaps the standard explanation is incomplete. The presentation uses that curiosity to make the viewer receptive to the parasite theory.

The emotional center of the VSL is the death of the narrator's daughter. The transcript says the daughter followed every recommendation but deteriorated after the COVID-19 vaccination period, was hospitalized, had unpredictable glucose, and died from a sudden cardiac arrest. The autopsy allegedly showed her pancreas was completely compromised.

This tragedy gives the narrator a reason to continue investigating. It also makes the pitch feel like a warning from someone who has suffered personally, not merely a commercial. Whether the viewer believes every claim or not, the narrative architecture is clear: standard treatment failed my family, Japan showed me an anomaly, and the hidden culprit explains what medicine missed.

Ads Breakdown

The ad transcript for Guruko Furudamu is shorter and more direct than the VSL. It focuses almost entirely on the parasite hook.

The opening question is designed to stop the scroll: 'Is there really a 2.5 centimeter parasite that lives in the pancreas?' That is a high-curiosity, high-fear hook. It combines a specific measurement, a hidden body location, and a disease people already fear.

The second line connects it directly to the target market: 'Is it really the cause of type 2?' The ad then answers affirmatively, claiming 18% of the population suffers from diabetes and less than 1% knows the real cause. This creates a knowledge gap: most people are allegedly unaware, but the viewer can become one of the few who knows.

The next ad angle rejects the standard diabetes narrative. It says type 2 has nothing to do with carbohydrates or sugar. That is an intentionally provocative claim because many diabetics have spent years thinking about carbs, desserts, meal timing, weight, and medication. By rejecting the familiar explanation, the ad makes the offer feel new.

Then the ad lists symptoms: tingling in the hands and feet, fatigue, excessive thirst, and frequent urination. These are recognizable concerns for people worried about blood sugar. The ad attributes them to the parasite, creating a bridge between everyday symptoms and the unique mechanism.

The solution is framed as fast and simple. The parasite is allegedly weak, and a simple herbal mixture can flush it out. The ad claims that in a few hours, the viewer can expel the parasite through urine and eliminate excess sugar. Within days, it says symptoms will disappear. Again, these are advertising claims from the transcript, not verified outcomes.

The final traffic-driving angle is suppression. The ad says the recipe is upsetting to people who profit from diabetes and that they will try to take the video down 'at any cost.' This creates urgency and reactance. The viewer is not just invited to watch; they are told access may vanish because powerful interests do not want them to see it.

In short, the ad uses five major hooks: parasite in the pancreas, hidden root cause, not sugar or carbs, fast herbal flush, and censored video urgency. It is built for curiosity clicks, especially from people dissatisfied with conventional diabetes management.

Psychological Triggers and Persuasion Tactics

The first major trigger is fear. The VSL opens by associating diabetes medications with cancer, cellular damage, and death. It also describes pancreatic cancer, compromised organs, sexual dysfunction, immune weakness, neuropathy, ulcers, amputation fears, and sudden cardiac arrest. This is not gentle wellness copy. It is high-intensity fear-based marketing.

The second trigger is betrayal. The viewer is told that the institutions meant to help them may be harming them. Big Pharma, politicians, doctors trained to treat symptoms, and major media outlets are positioned as part of a system that hides the truth. That framing can be very persuasive for someone who already feels failed by treatment.

The third trigger is the unique mechanism. Direct-response offers often need a reason the viewer has not succeeded before. The VSL says the reason is that they were targeting the wrong thing. Diet, sugar, stress, sleep, and medication are portrayed as surface-level issues, while the diabetes parasite is presented as the true root cause.

The fourth trigger is authority. The narrator claims to be a doctor, a Johns Hopkins graduate, and a professional with 28 years of experience. She says she has helped over 5,500 families and applied the method to over 5,000 patients. These claims are used to create trust, although the transcript does not provide external verification.

The fifth trigger is personal loss. The death of the narrator's daughter is the emotional engine of the VSL. It explains why the narrator is motivated, why the issue is urgent, and why she is willing to expose herself despite alleged risk. This kind of story can be powerful because it turns a supplement pitch into a mission.

The sixth trigger is social proof by volume. The transcript says hundreds attend lectures, hundreds ask daily for the method, and many people have transformed their lives. However, the provided transcript does not include actual buyer testimonials in the form of complete first-person customer quotes. The proof is mostly narrator-reported, not directly customer-quoted.

The seventh trigger is forbidden knowledge. The ad says the video may be taken down. The VSL says the viewer will not hear this elsewhere. This makes watching the video feel like accessing information before it disappears.

The eighth trigger is relief from blame. The narrator says, 'It's not your fault that your blood sugar levels are high.' This is emotionally important. Many diabetics carry guilt around food, weight, or discipline. The VSL removes blame and transfers responsibility to an external enemy: the alleged parasite and the pharmaceutical system.

Scientific and Authority Signals

The presentation uses scientific and authority language, but it does not provide detailed scientific substantiation in the supplied transcript.

The most prominent authority signal is Yumi Takahashi, described as a doctor specializing in nutrition and health, a 1996 Johns Hopkins University graduate, and a physician with 28 years of experience. She says she is invited to podcasts, gives lectures, and has dedicated her life to sharing her discoveries.

The VSL also uses anatomical and medical terms: pancreas, insulin, beta cells, immune system, insulin resistance, diabetic neuropathy, pancreatic cancer, cardiac arrest, and systemic collapse. These terms give the presentation a clinical feel, even when the claims themselves are not supported with citations inside the transcript.

The most specific research-style claim is that recent studies indicate the alleged silent enemy is responsible for 96% of diabetes cases. The problem is that the VSL does not identify those studies. There is no study title, no journal, no author, no year, no sample size, and no link. For a claim that large, the absence of details is significant.

Another authority signal is geographic: Japanese longevity and low diabetes rates. The VSL claims annual diabetes rankings show places such as Nakagawa, Okinawa, and Nagano have diabetes rates of only about 0.5%. Again, the transcript does not name the ranking source.

The VSL also relies on observational contrast: older Japanese people allegedly eat sweets daily and still avoid diabetes. This is presented as evidence that diet is not the root cause. But an anecdote about a grandfather's glucose reading of 108 after a meal is not the same as controlled scientific evidence.

This does not mean every claim is automatically false. It means the transcript does not give enough evidence to verify them. A research-first review has to say that clearly. The VSL uses authority signals, but the provided text does not provide the kind of transparent evidence a careful medical or scientific claim would require.

What Real Buyers Say

The provided transcript does not contain 10 to 15 complete first-person buyer testimonials. It mentions patients, families, lecture attendees, and people who allegedly shared results, but it does not give direct customer quotes that can be attributed to real buyers.

The closest testimonial-like material comes from narrator-reported claims. The speaker says she helps over 5,500 families break free from diabetes. She says the method was applied to over 5,000 patients. She says hundreds of people attend lectures to share results and that many have told her they were amazed something so simple could reverse a condition that kills millions every year.

But those are not the same as testimonials. A true testimonial would usually include a buyer's own words, context, time frame, and specific result. The transcript does not provide that. It also does not provide names, before-and-after labs, medical records, third-party verification, or disclaimers around typicality.

The VSL does include first-person emotional statements from the narrator, such as describing the loss of her daughter and the helplessness she felt as a doctor. Those statements build trust and empathy, but they are not buyer reviews of Guruko Furudamu.

For readers researching Guruko Furudamu reviews, this is a key point. The offer uses strong social proof claims by number, but the supplied transcript does not let us evaluate real customer experiences. Any claim about buyers becoming medication-free, reversing diabetes, or seeing results in seven days should be treated as a claim made by the presentation unless supported elsewhere by reliable evidence.

The Offer / Pricing / Risk Reversal

The provided transcript does not disclose the Guruko Furudamu price. There is no mention of a single-bottle cost, bundle discount, subscription, shipping fee, payment plan, or checkout structure.

It also does not mention a guarantee. Many supplement VSLs include a 60-day, 90-day, 180-day, or 365-day money-back guarantee, but no such guarantee appears in the supplied transcript. Because it is not in the transcript, we cannot claim one exists.

What the VSL does use is price anchoring. The narrator tells viewers they will stop wasting time and money on hospitals and clinics and save thousands on diabetes medications that allegedly do not address the root cause. The currency reference says 'thousands of reais', which suggests the script may have been adapted for a Brazilian or Portuguese-speaking market, though the provided transcript is in English.

The offer also uses scarcity, but not in the form of limited inventory. The ad says viewers should click while the video is still available because people who profit from diabetes will try to take it down. That is a suppression-based scarcity angle: the risk is not that the product sells out, but that the information disappears.

Bonuses are not mentioned in the provided transcript. There is no meal plan bonus, recipe guide, detox protocol, VIP coaching, app, or report described in the excerpt. The only implied bonus-like asset is access to the video that shows how to prepare the recipe, according to the ad.

As an offer, Guruko Furudamu is therefore incomplete in the transcript. The sales argument is visible, but the commercial terms are not. A buyer would need to see the checkout page, refund policy, product label, contact information, and terms before making a decision.

Who This Is For (and Who It Isn't)

Based on the transcript, Guruko Furudamu is written for adults who are frustrated with diabetes management. The ideal viewer is someone who checks glucose often, feels anxious about readings, has tried medication changes, and still feels stuck. It is also aimed at people who distrust pharmaceutical companies or feel conventional medicine only treats symptoms.

The VSL also speaks to people who want permission to believe their diabetes is not their fault. By saying blood sugar is not caused by sugar, fast food, stress, or sleep, the presentation relieves guilt and offers a new explanation. That can be emotionally appealing to someone exhausted by diet restrictions and constant monitoring.

The offer may also resonate with people drawn to Japanese longevity stories, hidden-cause theories, and natural remedies. The Nagano grandfather scene is designed for exactly that reader: someone who sees an apparent contradiction and wants to know the secret.

However, this is not for people looking for a transparent supplement label in the provided transcript. If you want named ingredients, dosages, clinical citations, drug-interaction information, or verified customer outcomes, the supplied VSL does not provide enough.

It is also not a substitute for medical care. The presentation criticizes diabetes medications heavily, but diabetes can be dangerous when unmanaged. Anyone using insulin, Metformin, GLP-1 medications, or other therapies should speak with a qualified clinician before changing anything.

Finally, it is not for readers who require evidence before accepting a disease mechanism. The idea that a 2.5 centimeter pancreatic parasite is the root cause of type 2 diabetes is the central marketing hook, but the provided transcript does not substantiate it with named studies or clinical documentation.

Frequently Asked Questions

What is Guruko Furudamu?
Guruko Furudamu is presented as a diabetes or blood sugar support offer promoted through a VSL. The transcript frames it around a claimed root cause of diabetes, but does not clearly disclose the product format.

Does the Guruko Furudamu transcript disclose the ingredients?
No. The transcript does not name confirmed Guruko Furudamu ingredients. The ad only refers to a simple herbal mixture, without naming the herbs or dosages.

What is the main claim in the Guruko Furudamu VSL?
The main claim is that an alleged diabetes parasite lodges in the pancreas, damages insulin-producing cells, and drives insulin resistance. This is the manufacturer's presentation claim, not a proven fact established by the transcript.

Does Guruko Furudamu claim diabetes is caused by sugar?
No. The VSL claims sugar, soda, fast food, stress, sleep, and emotions are not the real root cause. It says these may cause temporary spikes but not long-term elevated glucose.

Are there buyer testimonials in the transcript?
The transcript mentions patients, families, and lecture attendees, but it does not provide complete first-person buyer testimonial quotes. Social proof is mostly narrator-reported.

How much does Guruko Furudamu cost?
The supplied transcript does not mention a price, discount, bundle, shipping cost, or guarantee.

What is the Guruko Furudamu ad hook?
The ad hook claims a 2.5 centimeter parasite lives in the pancreas and causes type 2 diabetes. It also claims a herbal mixture can flush it out through urine and that the video may be taken down.

Is this medical advice?
No. This review analyzes the marketing transcript. Diabetes decisions should be made with qualified healthcare professionals.

Final Take

Guruko Furudamu is built around one of the most aggressive diabetes VSL mechanisms in the supplement space: the claim that type 2 diabetes is caused by a hidden pancreatic parasite, not sugar, carbohydrates, stress, sleep, or genetics. The story uses fear of medication harm, distrust of Big Pharma, Japanese longevity, a doctor's personal tragedy, and fast-result promises to create a strong emotional case.

As a piece of direct-response marketing, it is carefully constructed. The hook is unusual, the villain is clear, the narrator has authority, and the story gives the viewer a reason to believe standard diabetes care may have missed something. The ad version compresses that into a simple click driver: parasite in the pancreas, herbal flush, video may disappear.

As a research document, however, the provided transcript leaves major gaps. It does not disclose a confirmed ingredient list. It does not name the studies behind its biggest claims. It does not provide a price or guarantee. It does not include complete buyer testimonials. And it makes strong health-related claims that should not be accepted as fact without independent medical evidence.

The most responsible conclusion is this: Guruko Furudamu's VSL is a high-emotion, high-curiosity diabetes offer with a distinctive parasite mechanism, but the provided transcript does not give enough transparent product or scientific detail to validate the claims. Anyone considering it should treat the presentation as marketing, review the actual label and terms, and consult a qualified healthcare professional before making any diabetes-related decision.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.

Comments(0)

No comments yet. Members, start the conversation below.

Comments are open to Daily Intel members ($29.90/mo) and reviewed before publishing.

Private Group · Spots Open Sporadically

Stop burning budget on blind tests. Use what's already scaling.

validated VSLs & ads. 50–100 fresh every day at 11PM EST. major niches. Manual research — real devices, real purchases, real funnel data. No bots. No recycled scrapes. No upsells. No hidden tiers.

Not a "spy tool"

We don't run campaigns. Don't work with affiliates. Don't produce offers. Zero conflicts of interest — your win is our only business.

Not recycled data

50–100 new reports delivered daily at 11PM EST — manually verified, cloaker-passed. Not stale scrapes from months ago.

Not a lock-in

Cancel any time. No contracts. Your permanent rate locks in the day you join — $29.90/mo forever.

$299/mo$29.90/moRate Locked Forever

Secure checkout · Stripe · Cancel anytime · Back to home

VSLs & Ads Scaling Now

+50–100 Fresh Daily · Major Niches · $29.90/mo

Access